Skip to main content


Latest articles

21-06-2021 | Diabetes | News | Article

Leaflet intervention may reduce repeat ambulance callouts for hypoglycemia

Ambulance crews may be able to reduce the likelihood for repeat callouts to people with severe hypoglycemia by offering them advice and a leaflet on avoiding a second episode, a study suggests.

18-06-2021 | Diabetes | News | Article

Early polyneuropathy may be a risk factor for CVD

People with symptoms indicative of diabetic polyneuropathy near the time of type 2 diabetes diagnosis have a “markedly higher” risk for subsequent cardiovascular disease than those without, researchers report.

17-06-2021 | Diabetes | News | Article

Genetic ancestry interacts with social deprivation to modify type 2 diabetes risk

Genetic ancestry and socioeconomic deprivation are both significantly associated with type 2 diabetes risk, and may interact to modify that risk, study findings indicate.

16-06-2021 | Diabetes | News | Article

Prediction tool sheds light on contemporary CVD risk in type 1 diabetes

Researchers have created and validated a cardiovascular disease risk tool that substantially improves risk prediction in people with type 1 diabetes and indicates that statins may not always be needed in younger members of this group.

15-06-2021 | Diabetes | News | Article

Poor glycemic control, complications linked to dementia risk in people with type 2 diabetes

Among people with type 2 diabetes, those with hypoglycemic events, microvascular complications, or high or unstable glycated hemoglobin levels might have an increased risk for dementia, researchers report.

11-06-2021 | Diabetes | News | Article

Daily glycemic variability may contribute to aortic stiffness

Higher daily glucose variability is associated with greater aortic stiffness irrespective of average glucose levels, indicate findings from The Maastricht Study.

10-06-2021 | Diabetes | News | Article

Steep eGFR drop on SGLT2 inhibitor initiation may pose cardiorenal risk

The small proportion of people who experience an eGFR fall of more than 30% on starting an SGLT2 inhibitor may be at increased risk for adverse outcomes, research suggests.

09-06-2021 | Diabetes | News | Article

Stalling diabetes control could spell oncoming trouble for USA

NHANES data indicate that glycemic and blood pressure control in people with diabetes in the USA has deteriorated over recent years, and lipid control has plateaued.

08-06-2021 | Diabetes | News | Article

Widespread diabetes screening makes existing vascular risk prediction tools redundant

Implementation of widespread screening for diabetes “radically” alters the cardiovascular risk profile of people with newly detected diabetes, rendering existing cardiovascular risk prediction tools inaccurate, say researchers.

07-06-2021 | Diabetes | News | Article

Better glycemic control with isCGM may lead to less diabetes distress

Gaining greater control of blood glucose and hypoglycemia awareness is associated with a reduction in diabetes distress among people who start using the FreeStyle Libre, researchers report.

06-06-2021 | Diabetes | News | Article

Sexual dysfunction affects a third of people with diabetes

Around a third of people with type 1 or type 2 diabetes report some form of sexual dysfunction, with diabetes distress an underlying factor for both men and women, research shows.

05-06-2021 | Diabetes | News | Article

AI may facilitate fully closed-loop insulin delivery

A closed-loop system with an artificial intelligence component that rapidly detects when the user is eating a meal may offer a route towards fully closed-loop insulin delivery, shows a small crossover trial in adolescents and young adults.

05-06-2021 | Diabetes | News | Article

Forthcoming consensus statement offers guidance on DIY closed-looping

A consensus statement covering the practical, ethical, and legal aspects of the use of open-source closed-loop insulin delivery algorithms is soon to be published, the authors reported at the virtual ATTD 2021 conference.

05-06-2021 | Diabetes | News | Article

FDA approves higher semaglutide dose for obesity

Click through to read more on this announcement

04-06-2021 | Diabetes | News | Article

‘Smart’ questionnaire could refocus diabetes consultations

Completing a brief, adaptive questionnaire prior to each consultation with healthcare providers can focus discussions toward the immediate priorities and concerns of people with diabetes, shows a feasibility study.

03-06-2021 | Diabetes | Article

Severe hypoglycemia detrimental to long-term cognition in type 1 diabetes

Two studies, including a long-term DCCT analysis, highlight the importance of severe hypoglycemia in the risk for people with type 1 diabetes developing dementia.

02-06-2021 | Diabetes | News | Article

Studies support wider CGM access in type 2 diabetes

The results of two studies published in JAMA indicate that real-time continuous glucose monitoring benefits people with type 1 or type 2 diabetes on a range of insulin regimens and from a wide variety of backgrounds.

02-06-2021 | Diabetes | News | Article

ALERTT1: Time in range, hypoglycemia worry improve with isCGM to rtCGM switch

Switching from intermittently scanned to real-time continuous glucose monitoring improves time in range by a clinically relevant percentage, show the findings of the 6-month ALERTT1 trial.

02-06-2021 | Rheumatology | News | Article

Genetic data clarify relationship between hyperuricemia and insulin resistance

Insulin resistance has a causal effect on hyperuricemia and subsequently gout, but hyperuricemia does not impact insulin resistance, suggests an analysis of genome-wide association data.

01-06-2021 | Diabetes | News | Article

Prediabetic, high normal HbA1c levels linked to subclinical atherosclerosis risk

The risk for subclinical atherosclerosis among people at low risk for cardiovascular death increases with increasing glycated hemoglobin levels and is raised even at levels below the prediabetes threshold, research shows.